Shandong Tianming Pharmaceutical stands at the forefront of this field, achieving large-scale commercial production of key Avibactam intermediates with advanced synthesis technology and rigorous quality control.
Pharmaceutical excipients, once seen as fillers, are now vital in drug formulation. They enhance stability, solubility, and patient compliance, while supporting safe, effective, and sustainable drug development.
Pharmacovigilance is more than just monitoring adverse drug reactions—it is a dynamic safety system that directly involves API manufacturers. Changes in impurities, synthesis routes, or process modifications can affect drug safety and trigger regulatory scrutiny.
Orforglipron is the first oral, non-peptide GLP-1 agonist with high bioavailability and strong efficacy in lowering glucose and weight. Precise synthesis and high-quality intermediates are crucial to ensure its success in drug development.
Confused about the difference between drugs and health foods? This article explains their regulatory definitions, registration requirements, R&D costs, side effects, and consumer positioning. Understanding these distinctions helps consumers make smarter health decisions.
Learn which foods are rich in PQQ and how to maintain a balanced intake. Adding these foods to your diet helps enhance cognitive function, fight fatigue, and protect overall health.
The European Food Safety Authority (EFSA) has begun the approval process for NMN as a novel food, marking a breakthrough in global compliance. This milestone may accelerate NMN’s role in anti-aging, energy metabolism, and health supplements, shaping a new era in nutrition and wellness.
This guide clarifies distinctions between brand-name drugs, generics, and APIs, emphasizing bioequivalence, cost efficiency for chronic conditions, and safety warnings.
Leading provider of high-quality APIs and intermediates. Contact us for innovative solutions and expert support.
